发明授权
- 专利标题： Amorphous carvedilol dihydrogen phosphate
- 专利标题（中）： 无定形卡维地洛磷酸二氢盐
-
申请号： US12387913申请日： 2009-05-08
-
公开(公告)号： US08114900B2公开(公告)日： 2012-02-14
- 发明人: Santiago Ini , Sigalit Levi , Mili Abramov , Eran Turgeman
- 申请人： Santiago Ini , Sigalit Levi , Mili Abramov , Eran Turgeman
- 申请人地址： IL Petah Tiqva
- 专利权人： Teva Pharmaceutical Industries Ltd.
- 当前专利权人： Teva Pharmaceutical Industries Ltd.
- 当前专利权人地址： IL Petah Tiqva
- 代理机构： Kenyon & Kenyon LLP
- 主分类号： A61K31/404
- IPC分类号： A61K31/404 ; C07D209/88 ; A61P9/00
摘要：
The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
公开/授权文献
- US20090286844A1 Carvedilol phosphate 公开/授权日：2009-11-19